Delivery Order SPE2DB22D3016-SPE2DB25FAKZ7

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. The $2,070.60 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. is a Delivery Order with a Firm Fixed Price valued at $1,761.96. The contract is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical supply item, with a completion date of January 10, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical that runs through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,618.96 Firm Fixed Price delivery order is for PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.60 firm fixed-price delivery order contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has a completion date of December 23, 2024 and was awarded on December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,644.68 firm fixed-price delivery order contract is for the provision of PROCTOFOAM 10GM 1S medical supplies, with a completion date of November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,048.00 Firm Fixed Price Delivery Order is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product, with a completion date of January 27, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,026.00 Firm Fixed Price Delivery Order is for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of October 12, 2023 and was awarded on October 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,033.01 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of Proctofoam-HC 1%-1% Foam in 10 gram units. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM. The $6,084.66 firm fixed-price contract has an ultimate completion date of November 5, 2024. This award is a delivery order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,823.40 firm fixed-price delivery order is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAKZ7
    Delivery Order

This federal contract award is for the delivery of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,651.98 firm fixed-price delivery order has a completion date of January 23, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/23/25, 12:05 PM